Company news: Daiichi Sankyo, Astellas, Takeda

Share this article:
Japanese pharma giants are taking stock of the damage from last Friday's Tohoku Earthquake and tsunami. Tokyo-based Daiichi Sankyo said all its employees were safe and accounted for, though a few had suffered minor injuries. The company said two plants were partly damaged by the earthquake, and sales and marketing activities at several branches in hard-hit areas had been halted. Astellas, also based in Tokyo, said it had confirmed that all of its and its affiliates' employees were safe, but that operations at two manufacturing plants and a chemistry lab had been halted and marketing employees based in devastated regions instructed to remain on standby at home. Osaka-based Takeda announced it would donate 300 million yen and pharmaceutical products to relief efforts.

The pharmaceutical industry ranked well in The National Association of Female Executives' annual list of the top 50 companies for female executives. Among the companies that made the list were Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Lilly, J&J, Merck and Pfizer.
Share this article:

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.